Chen Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chen Xu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Guangyu Qiu
Shanghai Jiao Tong University
4 shared publications - Abhimanyu Thakur
The Pritzker School of Molecular Engineering, the University of Chicago
2 shared publications - Chi-Man Lawrence Wu
Department of Materials Science and Engineering, City University of Hong Kong, Hong Kong, China
2 shared publications Siu‐Pang Ng
Department of Materials Science and Engineering City University of Hong Kong 83 Tat Chee Avenue Kowloon Hong Kong SAR 999077 China
2 shared publications- Youngjin Lee
Sungkyunkwan University
2 shared publications Abhimanyu Thakur
Department of Biomedical Sciences City University of Hong Kong 83 Tat Chee Avenue Kowloon Hong Kong SAR 999077 China
1 shared publication
Latest Publications
- 1 September 2020
- Published by Elsevier in Ceramics International
- Vol. 46 (13) , 20993-20999
Nanostructured titanium nitride for highly sensitive localized surface plasmon resonance biosensing
- 1 September 2020
- Published by Elsevier in Ceramics International
- Vol. 46 (13) , 20993-20999
Nanostructured titanium nitride for highly sensitive localized surface plasmon resonance biosensing
- Open Access
- 26 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (26) , eaaz6119
Label-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma
Noninvasive detection of exosomal MCT1/CD147 can monitor the progression of glioma, a fatal brain tumor, as a liquid biopsy.
- 26 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (26) , eaaz6119
Open AccessLabel-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma
Noninvasive detection of exosomal MCT1/CD147 can monitor the progression of glioma, a fatal brain tumor, as a liquid biopsy.
- Open Access
- 27 February 2019
- Published by Wiley in Advanced Functional Materials
- Vol. 29 (9)
Sensors/Biosensors: Detection of Glioma‐Derived Exosomes with the Biotinylated Antibody‐Functionalized Titanium Nitride Plasmonic Biosensor (Adv. Funct. Mater. 9/2019)
- 27 February 2019
- Published by Wiley in Advanced Functional Materials
- Vol. 29 (9)
Open AccessSensors/Biosensors: Detection of Glioma‐Derived Exosomes with the Biotinylated Antibody‐Functionalized Titanium Nitride Plasmonic Biosensor (Adv. Funct. Mater. 9/2019)
- 20 December 2018
- Published by Wiley in Advanced Functional Materials
- Vol. 29 (9)
Detection of Glioma‐Derived Exosomes with the Biotinylated Antibody‐Functionalized Titanium Nitride Plasmonic Biosensor
Titanium nitride (TiN), as an excellent alternative plasmonic supporting material compared to gold and silver, exhibits tunable plasmonic properties in the visible and near‐infrared spectra. However, label‐free surface plasmon resonance biosensing with TiN is seldom reported due to lack of proper surface functionalization protocols. Herein, this study reports biotinylated antibody‐functionalized TiN (BAF‐TiN) for high‐performance label‐free biosensing applications. The BAF‐TiN biosensor can quantitatively detect exosomes of 30–200 nm extracellular vesicles, isolated from a human glioma cell line. The limit of detection for an exosomal membrane protein with the BAF‐TiN biosensor is found to be 4.29 × 10−3µg mL−1 for CD63, an exosome marker, and 2.75 × 10−3µg mL−1 for epidermal growth factor receptor variant‐III, a glioma specific mutant protein, respectively. In conclusion, combining the biocompatibility, high stability, and excellent label‐free sensing performance of TiN, the BAF‐TiN biosensor could have great potential for the detection of cancer biomarkers, including exosomal surface proteins.
- 20 December 2018
- Published by Wiley in Advanced Functional Materials
- Vol. 29 (9)
Detection of Glioma‐Derived Exosomes with the Biotinylated Antibody‐Functionalized Titanium Nitride Plasmonic Biosensor
Titanium nitride (TiN), as an excellent alternative plasmonic supporting material compared to gold and silver, exhibits tunable plasmonic properties in the visible and near‐infrared spectra. However, label‐free surface plasmon resonance biosensing with TiN is seldom reported due to lack of proper surface functionalization protocols. Herein, this study reports biotinylated antibody‐functionalized TiN (BAF‐TiN) for high‐performance label‐free biosensing applications. The BAF‐TiN biosensor can quantitatively detect exosomes of 30–200 nm extracellular vesicles, isolated from a human glioma cell line. The limit of detection for an exosomal membrane protein with the BAF‐TiN biosensor is found to be 4.29 × 10−3µg mL−1 for CD63, an exosome marker, and 2.75 × 10−3µg mL−1 for epidermal growth factor receptor variant‐III, a glioma specific mutant protein, respectively. In conclusion, combining the biocompatibility, high stability, and excellent label‐free sensing performance of TiN, the BAF‐TiN biosensor could have great potential for the detection of cancer biomarkers, including exosomal surface proteins.